Evidence map›Paper›PMID 19389847›Full record

ArticleJournal of the American Society of Nephrology : JASN2009

Mesenchymal stem cell-derived microvesicles protect against acute tubular injury.

Stefania Bruno, Cristina Grange, Maria Chiara Deregibus, Raffaele A Calogero, Silvia Saviozzi, Federica Collino, Laura Morando, Alessandro Busca, Michele Falda, Benedetta Bussolati and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 704 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
704citing papers in PubMed, 4 pooled it
15.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

704 citing papers in PubMed, 4 syntheses or guidelines pooled it, 1,308 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Integrative Approaches to Treating Cellular Senescence in Kidney Disease.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

644 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Stefania BrunoDepartment of Internal Medicine, Research Center for Experimental Medicine, University of Torino, Torino, Italy.
Cristina Grange
Maria Chiara Deregibus
Raffaele A Calogero
Silvia Saviozzi
Federica Collino
Laura Morando
Alessandro Busca
Michele Falda
Benedetta Bussolati
Ciro Tetta
Giovanni Camussi
Azienda Ospedaliero Universitaria San Giovanni Battista · ITUniversity of Turin · ITFresenius Medical Care (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Administration of mesenchymal stem cells (MSCs) improves the recovery from acute kidney injury (AKI). The mechanism may involve paracrine factors promoting proliferation of surviving intrinsic epithelial cells, but these factors remain unknown. In the current study, we found that microvesicles derived from human bone marrow MSCs stimulated proliferation in vitro and conferred resistance of tubular epithelial cells to apoptosis. The biologic action of microvesicles required their CD44- and beta1-integrin-dependent incorporation into tubular cells. In vivo, microvesicles accelerated the morphologic and functional recovery of glycerol-induced AKI in SCID mice by inducing proliferation of tubular cells. The effect of microvesicles on the recovery of AKI was similar to the effect of human MSCs. RNase abolished the aforementioned effects of microvesicles in vitro and in vivo, suggesting RNA-dependent biologic effects. Microarray analysis and quantitative real time PCR of microvesicle-RNA extracts indicate that microvesicles shuttle a specific subset of cellular mRNA, such as mRNAs associated with the mesenchymal phenotype and with control of transcription, proliferation, and immunoregulation. These results suggest that microvesicles derived from MSCs may activate a proliferative program in surviving tubular cells after injury via a horizontal transfer of mRNA.

Indexed as

AnimalsCell DivisionCell TransplantationFlow CytometryGenes, ReporterGlycerolKidney DiseasesKidney TubulesMesenchymal Stem CellsMesenchymal Stem Cell TransplantationMiceMice, SCIDOligonucleotide Array Sequence AnalysisRNA, MessengerGlycerolRNA, Messenger

Identifiers

PMID19389847
PMCPMC2676194
OpenAlexW2154215235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.